IP Library Granted Patent US 7,208,601
Granted Patent B2
US 7,208,601 · App. 11/069,521 · Granted Apr 24, 2007

Aryl and heteroaryl compounds, compositions, and methods of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,208,601
App. No.
11/069,521
Granted
Apr 24, 2007
Kind
B2
Abstract

This invention provides aryl and heteroaryl compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention may be useful as antagonists, or partial antagonist of factor IX and/or factor XI and thus, may be used to inhibit the intrinsic pathway of blood coagulation. The compounds may be useful in a variety of applications including the management, treatment and/or control of diseases caused in part by the intrinsic clotting pathway utilizing factor IX and/or XI.

Claims (86)

1. A compound of Formula (X),

wherein

R 101 is selected from the group consisting of —H, or —CH 2 -thienyl wherein the thienyl group in —CH 2 -thienyl is optionally substituted with —Br or —CH 3 ;

R 102 is selected from the group consisting of —C(O)OH, —C(O)OCH 3 , —C(O)O-t-butyl,

—C(O)NH—OCH 2 -phenyl, —C(O)NHOH, and —C(O)NHSO 2 CH 3 ;

R 103 is selected from the group consisting of —H, —CH 2 -thienyl, —CH 2 -phenyl, —CH 2 -furanyl, -thienyl, and benzothienyl wherein each of the above possibilities for R 103 except —H are optionally substituted with one or more members selected from group consisting of

—H, —CH 3 , —CF 3 , —Cl, —Br, —F, —C(O)CH 3 , —CH 2 CH 3 , —CH═CH 2 , —CH 2 OH,

—CH(CH 3 ) 2 ,

—CH 2 CH 2 CH 3 ,

-propenyl, -3,3-dimethyl-butenyl, -isopropenyl, -phenyl, -phenylene-methyl, -phenylene-propyl, -phenylene-trifluoromethyl, -phenylene-chloride, -cyclopentyl, -cyclopentenyl, and -furanyl;

R 104 is selected from the group consisting of —O-cyclohexylene-ethyl, —O-cyclohexylene-t-butyl, —O-cyclohexylene-i-propyl, —O-phenylene-t-butyl, -phenylene-t-butyl, and

—C(O)-phenylene-t-butyl;

and Y is selected from the group consisting of —H, -methylene-cyclopentyl, -amino-cyclohexyl, -methylene-thienylene-methyl, methylene-thienylene-bromide, and tetrahydropyranyl;

or a pharmaceutically acceptable salt, ester, or prodrug thereof.

2. A compound of Formula (X),

wherein R 101 , is selected from the group consisting of —H, or —CH 2 -thienyl wherein the thienyl group in —CH 2 -thienyl is optionally substituted with —Br or —CH 3 ;

R 102 is selected from the group consisting of —C(O)OH, —C(O)OCH 3 , —C(O)O-t-butyl,

—C(O)NH—OCH 2 -phenyl, —C(O)NHOH, and —C(O)NHSO 2 CH 3 ;

R 103 is selected from the group consisting of —H, —CH 2 -thienyl, —CH 2 -phenyl, —CH 2 -furanyl, thienyl, and benzothienyl wherein each of the above possibilities for R 103 except —H are optionally substituted with one or more members selected from group consisting of

—H, —CH 3 , —CF 3 , —Cl, —Br, —F, —C(O)CH 3 , —CH 2 CH 3 , —CH═CH 2 , —CH 2 OH,

—CH(CH 3 ) 2 , —CH 2 CH 2 CH 3 ,

R 104 is selected from the group consisting of

and Y is selected from the group consisting of H,

or a pharmaceutically acceptable salt, ester, or prodrug thereof.

3. The compound according to claim 2 , wherein R 104 is

4. The compound according to claim 2 , wherein R 103 is optionally substituted —CH 2 -2-yl-thienyl or optionally substituted —CH 2 -phenyl.

5. The compound according to claim 2 , wherein R 103 is optionally substituted —CH 2 -2-yl-thienyl.

6. The compound according to claim 3 , wherein R 101 is —H.

7. The compound according to claim 3 , wherein Y is selected from the group consisting of

8. The compound according to claim 2 , wherein the compound of Formula (X) is selected from the group consisting of

2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-phenyl-thiophen-2-yl)-propionic acid,

2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-[5-(4-trifluoromethyl-phenyl)-thiophen-2-yl]-propionic acid,

2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-cyclopent-1-enyl-thiophen-2-yl)-propionic acid methyl ester,

2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-cyclopent-1-enyl-thiophen-2-yl)-propionic acid,

2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-cyclopentyl-thiophen-2-yl)-propionic acid methyl ester,

2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-cyclopentyl-thiophen-2-yl)-propionic acid,

2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-furan-3-yl-thiophen-2-yl)-propionic acid,

2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-[5-(4-isopropyl-phenyl)-thiophen-2-yl]-propionic acid,

2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-vinyl-thiophen-2-yl)-propionic acid,

2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-p-tolyl-thiophen-2-yl)-propionic acid,

2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-[5-(4-chloro-phenyl)-thiophen-2-yl]-propionic acid,

2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-ethyl-thiophen-2-yl)-propionic acid,

2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-furan-2-yl-propionic acid,

2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(2-trifluoromethyl-phenyl)-propionic acid,

{(5-Bromo-thiophen-2-ylmethyl)-[7-(4-tert-butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-acetic acid tert-butyl ester,

2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(3,5-difluorophenyl)-propionic acid,

[[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-(5-methyl-thiophen-2-ylmethyl)-amino]-acetic acid,

{(5-Bromo-thiophen-2-ylmethyl)-[7-(4-tert-butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-acetic acid methyl ester,

{(4-Bromo-thiophen-2-ylmethyl)-[7-(4-tert-butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-acetic acid,

{(5-Bromo-thiophen-2-ylmethyl)-[7-(4-tert-butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-acetic acid,

Benzo[b]thiophen-3-yl-{[7-(4-tert-butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-acetic acid,

2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(4-fluoro-phenyl)-propionic acid,

2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-propenyl-thiophen-2-yl)-propionic acid,

2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-propyl-thiophen-2-yl)-propionic acid,

2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-[5-(3,3-dimethyl-but-1-enyl)-thiophen-2-yl]-propionic acid,

2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-hydroxymethyl-thiophen-2-yl)-propionic acid methyl ester,

2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-hydroxymethyl-thiophen-2-yl)-propionic acid,

2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-methyl-thiophen-2-yl)-propionic acid,

2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-isopropenyl-thiophen-2-yl)-propionic acid,

2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-isopropylthiophen-2-yl)-propionic acid,

3-(5-Bromo-thiophen-2-yl)-2(R)-{[7-(4-tert-butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-propionic acid,

2(R)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-chloro-thiophen-2-yl)-propionic acid,

2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-chloro-furan-2-yl)-propionic acid,

2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(2,5-dichloro-thiophen-3-yl)-propionic acid,

(5-Bromo-thiophen-2-yl)-{[7-(4-tert-butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-acetic acid,

3-(5-Bromo-furan-2-yl)-2(S)-{[7-(4-tert-butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-propionic acid,

3-(5-Bromo-thiophen-2-yl)-2(S)-{[7-(4-trans-tert-butyl-cyclohexyloxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-propionic acid,

3-(5-Bromo-thiophen-2-yl)-2(S)-{[6-(4-tert-butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-propionic acid,

2(S)-{[7-(4-trans-tert-Butyl-cyclohexyloxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-isopropenyl-thiophen-2-yl)-propionic acid,

2(S)-{[7-(4-trans-tert-Butyl-cyclohexyloxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-isopropyl-thiophen-2-yl)-propionic acid,

2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-isopropyl-furan-2-yl)-propionic acid,

2(S)-{[1-Cyclopentylmethyl-7-(4-isopropyl-cyclohexyloxy)-isoquinoline-3-carbonyl]-amino}-3-(5-isopropyl-thiophen-2-yl)-propionic acid,

2(R)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-isopropyl-thiophen-2-yl)-propionic acid,

2(S)-{[7-(4-tert-Butyl-phenoxy)-isoquinoline-3-carbonyl]-amino}-3-(5-isopropyl-thiophen-2-yl)-propionic acid,

2(S)-{[1-Cyclopentylmethyl-7-(4-trans-ethyl-cyclohexyloxy)-isoquinoline-3-carbonyl]-amino}-3-(5-isopropyl-thiophen-2-yl)-propionic acid,

2(S)-{[1-Cyclopentylmethyl-7-(4-isopropyl-phenoxy)-isoquinoline-3-carbonyl]-amino}-3-(5-isopropyl-thiophen-2-yl)-propionic acid,

2(S)-{[7-(4-tert-Butyl-phenoxy)-1-(tetrahydro-pyran-4-yl)-isoquinoline-3-carbonyl]-amino}-3-(5-isopropyl-thiophen-2-yl)-propionic acid,

2(S)-{[6-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-isopropyl-thiophen-2-yl)-propionic acid,

2(S)-{[7-(4-tert-Butyl-phenyl)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-isopropyl-thiophen-2-yl)-propionic acid,

2(S)-{[7-(4-tert-Butyl-benzoyl)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-isopropyl-thiophen-2-yl)-propionic acid,

3-(5-Acetyl-thiophen-2-yl)-2(S)-{[7-(4-tert-butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-propionic acid,

7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carboxylic acid [1-(5-isopropyl-thiophen-2-ylmethyl)-2(R)-methanesulfonylamino-2-oxo-ethyl]-amide,

7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carboxylic acid [1-(5-isopropyl-thiophen-2-ylmethyl)-2(S)-methanesulfonylamino-2-oxo-ethyl]-amide,

7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carboxylic acid [1-benzyloxycarbamoyl-2-(5-isopropyl-thiophen-2-yl)-ethyl]-amide, and

7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carboxylic acid [1-hydroxycarbamoyl-2-(5-isopropyl-thiophen-2-yl)-ethyl]-amide.

9. The compound according to claim 2 , wherein Y is -methylene-cyclopentyl.

Assignments (3)
NOTICE OF RELEASE OF SECURITY INTEREST IN PATENTS FOR REEL/FRAME 030982/0803 Recorded Apr 7, 2014
From: M&F TTP HOLDINGS LLC
To: TRANSTECH PHARMA, LLC
Reel/Frame 032621/0860 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 22, 2013
From: TRANSTECH PHARMA, INC.
To: TRANSTECH PHARMA, LLC
Reel/Frame 031654/0878 →
SECURITY AGREEMENT Recorded Aug 9, 2013
From: TRANSTECH PHARMA, INC.
To: M&F TTP HOLDINGS LLC C/O MACANDREWS & FORBES HOLDINGS INC.
Reel/Frame 030982/0803 →